275 related articles for article (PubMed ID: 11470965)
1. The role of glial cells in Parkinson's disease.
Vila M; Jackson-Lewis V; Guégan C; Wu DC; Teismann P; Choi DK; Tieu K; Przedborski S
Curr Opin Neurol; 2001 Aug; 14(4):483-9. PubMed ID: 11470965
[TBL] [Abstract][Full Text] [Related]
2. Glial cell response: A pathogenic factor in Parkinson's disease.
Wu DC; Tieu K; Cohen O; Choi DK; Vila M; Jackson-Lewis V; Teismann P; Przedborski S
J Neurovirol; 2002 Dec; 8(6):551-8. PubMed ID: 12476349
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic role of glial cells in Parkinson's disease.
Teismann P; Tieu K; Cohen O; Choi DK; Wu DC; Marks D; Vila M; Jackson-Lewis V; Przedborski S
Mov Disord; 2003 Feb; 18(2):121-9. PubMed ID: 12539204
[TBL] [Abstract][Full Text] [Related]
4. Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation.
Teismann P; Schulz JB
Cell Tissue Res; 2004 Oct; 318(1):149-61. PubMed ID: 15338271
[TBL] [Abstract][Full Text] [Related]
5. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
6. Role of glial cells in neurotoxin-induced animal models of Parkinson's disease.
Yokoyama H; Uchida H; Kuroiwa H; Kasahara J; Araki T
Neurol Sci; 2011 Feb; 32(1):1-7. PubMed ID: 21107876
[TBL] [Abstract][Full Text] [Related]
7. Current opinions and perspectives on the role of immune system in the pathogenesis of Parkinson's disease.
Panaro MA; Cianciulli A
Curr Pharm Des; 2012; 18(2):200-8. PubMed ID: 22229581
[TBL] [Abstract][Full Text] [Related]
8. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease.
Gao HM; Jiang J; Wilson B; Zhang W; Hong JS; Liu B
J Neurochem; 2002 Jun; 81(6):1285-97. PubMed ID: 12068076
[TBL] [Abstract][Full Text] [Related]
9. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J
FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003
[TBL] [Abstract][Full Text] [Related]
10. Age and Parkinson's disease-related neuronal death in the substantia nigra pars compacta.
Eriksen N; Stark AK; Pakkenberg B
J Neural Transm Suppl; 2009; (73):203-13. PubMed ID: 20411779
[TBL] [Abstract][Full Text] [Related]
11. The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease.
Mirza B; Hadberg H; Thomsen P; Moos T
Neuroscience; 2000; 95(2):425-32. PubMed ID: 10658622
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
13. The role of glial reaction and inflammation in Parkinson's disease.
Hirsch EC; Breidert T; Rousselet E; Hunot S; Hartmann A; Michel PP
Ann N Y Acad Sci; 2003 Jun; 991():214-28. PubMed ID: 12846989
[TBL] [Abstract][Full Text] [Related]
14. Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state.
Smajić S; Prada-Medina CA; Landoulsi Z; Ghelfi J; Delcambre S; Dietrich C; Jarazo J; Henck J; Balachandran S; Pachchek S; Morris CM; Antony P; Timmermann B; Sauer S; Pereira SL; Schwamborn JC; May P; Grünewald A; Spielmann M
Brain; 2022 Apr; 145(3):964-978. PubMed ID: 34919646
[TBL] [Abstract][Full Text] [Related]
15. Acute Neuroinflammatory Response in the Substantia Nigra Pars Compacta of Rats after a Local Injection of Lipopolysaccharide.
Flores-Martinez YM; Fernandez-Parrilla MA; Ayala-Davila J; Reyes-Corona D; Blanco-Alvarez VM; Soto-Rojas LO; Luna-Herrera C; Gonzalez-Barrios JA; Leon-Chavez BA; Gutierrez-Castillo ME; Martínez-Dávila IA; Martinez-Fong D
J Immunol Res; 2018; 2018():1838921. PubMed ID: 29854828
[TBL] [Abstract][Full Text] [Related]
16. Role of chemokines in Parkinson's disease.
Liu JQ; Chu SF; Zhou X; Zhang DY; Chen NH
Brain Res Bull; 2019 Oct; 152():11-18. PubMed ID: 31136787
[TBL] [Abstract][Full Text] [Related]
17. Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats.
Lu X; Bing G; Hagg T
Neuroscience; 2000; 97(2):285-91. PubMed ID: 10799760
[TBL] [Abstract][Full Text] [Related]
18. Prolonged Dysfunction of Astrocytes and Activation of Microglia Accelerate Degeneration of Dopaminergic Neurons in the Rat Substantia Nigra and Block Compensation of Early Motor Dysfunction Induced by 6-OHDA.
Kuter K; Olech Ł; Głowacka U
Mol Neurobiol; 2018 Apr; 55(4):3049-3066. PubMed ID: 28466266
[TBL] [Abstract][Full Text] [Related]
19. Reactive astrocytes as potential manipulation targets in novel cell replacement therapy of Parkinson's disease.
Chen LW; Yung KL; Chan YS
Curr Drug Targets; 2005 Nov; 6(7):821-33. PubMed ID: 16305461
[TBL] [Abstract][Full Text] [Related]
20. Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?
Hirsch EC; Hunot S; Damier P; Faucheux B
Ann Neurol; 1998 Sep; 44(3 Suppl 1):S115-20. PubMed ID: 9749582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
